<DOC>
	<DOC>NCT01791413</DOC>
	<brief_summary>The purpose of this study is to evaluate the ovarian reserve changes after preoperative depot medroxyprogesterone acetate (DMPA) in women with ovarian endometrioma undergoing laparoscopic cystectomy.</brief_summary>
	<brief_title>Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<criteria>Healthy women 1840 years old A diagnosis of endometrioma with diameter of at least 3 cm. Candidates for laparoscopic cystectomy Patients' refusal to participate Not candidate for depot medroxyprogesterone acetate such as: cirrhosis, chronic kidney disease, venous thrombosis Use of estrogensuppressive drugs in the preceding 3 months, such as: Oral contraceptives, GnRH analogues, Progestins, Danazol Pathology report present no endometriosis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>